Earnings History Data for Bellerophon Therapeutics (BLPH) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Bellerophon Therapeutics
Bellerophon Therapeutics LLC is a biotherapeutics company. It is focused on developing products for the treatment of cardiopulmonary and cardiac diseases. The company's product pipeline consists of INOpulse and BCM which are in different clinical stage. Bellerophon Therapeutics LLC is based in Hampton, New Jersey.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 15-05-2023 | AH | After the close (May 15) |
BLPH | Bellerophon Therapeutics | 92.00 | 0.15 | -0.48 | 0.00 | Bellerophon Therapeutics GAAP EPS of $0.27, revenue of $5.64M [5/15/2023 5:31 PM] |
10.48 | 1.77 (20.32%) |
9.09 | 0.38 (4.36%) |
0.67 - 12.58 | 321,043 | 80,000 | 831 | |
| 31-03-2023 | PM | BLPH | Bellerophon Therapeutics, Inc. | 12.98 | -0.53 | -0.48 | -0.45 | Bellerophon Therapeutics GAAP EPS of -$2.08 misses by $0.06 [3/31/2023 8:42 AM] |
7.67 | 0.21 (2.88%) |
7.30 | -0.16 (-2.14%) |
0.67 - 8.44 | 56,923 | 300,000 | 3,436 | ||
| 14-11-2022 | PM | BLPH | Bellerophon Therapeutics | 11.00 | -0.53 | -0.59 | 0.00 | Bellerophon Therapeutics GAAP EPS of -$0.53 beats by $0.05 [11/14/2022 9:07 AM] |
1.12 | 0.02 (1.82%) |
0.0 | 0.0 (0.00%) |
0.67 - 3.90 | 2,589 | 0 | 0 | ||
| 15-08-2022 | PM | BLPH | Bellerophon Therapeutics | 13.00 | -0.43 | -0.61 | 0.00 | Bellerophon Therapeutics GAAP EPS of -$0.43 beats by $0.17 [8/15/2022 8:54 AM] |
1.42 | 0.0 (0.00%) |
0.0 | 0.0 (0.00%) |
0.67 - 4.49 | 9,098 | 20,000 | 0 | ||
| 11-05-2022 | PM | BLPH | Bellerophon Therapeutics, Inc. | 11.45 | -0.59 | -0.55 | -0.58 | Bellerophon Therapeutics GAAP EPS of -$0.59 misses by $0.04 [5/11/2022 8:41 AM] |
0.8730 | -0.02 (-2.60%) |
0.89 | 0.0 (-0.31%) |
0.67 - 5.95 | 134,998 | 50,000 | 106 | ||
| 15-11-2021 | PM | BLPH | Bellerophon Therapeutics | 31.00 | -0.49 | -0.63 | 0.00 | Bellerophon Therapeutics EPS beats by $0.14 [11/15/2021 8:58 AM] |
3.39 | 0.26 (8.12%) |
0.0 | 0.0 (0.00%) |
3.10 - 9.19 | 43,131 | 30,000 | 0 | ||
| 05-08-2021 | PM | BLPH | Bellerophon Therapeutics, Inc. | 40.59 | -0.36 | -0.66 | -0.51 | Bellerophon Therapeutics EPS beats by $0.25 [8/5/2021 9:11 AM] |
4.13 | 0.13 (3.25%) |
4.00 | 0.0 (0.00%) |
3.79 - 12.81 | 25,656 | 50,000 | 515 | ||
| 11-05-2021 | PM | BLPH | Bellerophon Therapeutics, Inc. | 38.69 | -0.58 | -0.71 | -0.89 | Bellerophon Therapeutics EPS beats by $0.13 [5/11/2021 8:56 AM] |
4.05 | -0.03 (-0.74%) |
4.00 | -0.08 (-1.96%) |
3.96 - 21.28 | 30,435 | 40,000 | 1,519 | ||
| 05-11-2020 | PM | 8:30 AM ET (Nov 5) |
BLPH | Bellerophon Therapeutics, Inc. | 82.06 | -0.84 | -0.82 | -0.90 | Bellerophon Therapeutics EPS misses by $0.01 [11/5/2020 8:38 AM] |
8.76 | 0.31 (3.67%) |
10.37 | 1.61 (18.38%) |
3.19 - 26.00 | 39,952 | 35,284 | 202 | |
|
|
||||||||||||||||||